Testing effectiveness (Phase 2)Ended earlyNCT02559817
What this trial is testing
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Who this might be right for
Irritable Bowel Syndrome With Constipation
Forest Laboratories 101